To describe a unique pattern of cutaneous immune-related adverse events triggered by pembrolizumab.
Detailed case report of a patient experiencing specific skin reactions to pembrolizumab.
Clinical observations and photographic documentation of the skin manifestations.
The patient exhibited a unilateral mosaic pattern of skin changes.
The adverse events were associated with pembrolizumab treatment, diverging from typical presentations.
Abstract
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.